Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer

J Geriatr Oncol. 2018 May;9(3):281-283. doi: 10.1016/j.jgo.2017.11.003. Epub 2017 Nov 22.
No abstract available

Keywords: Elderly; Eribulin; Metastatic breast cancer; Toxicity.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Breast Neoplasms / drug therapy*
  • Female
  • Furans / administration & dosage*
  • Furans / adverse effects
  • Humans
  • Ketones / administration & dosage*
  • Ketones / adverse effects
  • Neoplasm Metastasis / drug therapy
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Furans
  • Ketones
  • eribulin